Rodent models of ischemic stroke lack translational relevance... are baboon models the answer?

Neurological Research

Volumn 36, Issue 5, 2014, Pages 417-422

  Kwiecien, Timothy D ^a   Sy, Christopher ^a   Ding, Yuchuan ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Animal model; Baboon; Monkey; Mouse; Rat; Therapy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; BRAIN FUNCTION; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); EXPERIMENTAL STUDY; INFLAMMATION; MIDDLE CEREBRAL ARTERY; NEUROLOGIC EXAMINATION; NONHUMAN; PHYSIOLOGY; TRANSLATIONAL RESEARCH; VASCULAR DISEASE; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; RAT; RODENT;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; HUMANS; MICE; PAPIO; RATS; RODENTIA; STROKE; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84898768931     PISSN: 01616412     EISSN: 17431328     Source Type: Journal    
DOI: 10.1179/1743132814Y.0000000358     Document Type: Article

References (51)

1. Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet. 2008;371:1612-23.
2. Seshadri S, Beiser A, Kelly-Hayes M, Kase CS, Au R, Kannel WB, et al. The lifetime risk of stroke: estimates from the Framingham study. Stroke. 2006;37:345-50.
3. Warlow CP. Epidemiology of stroke. Lancet. 1998;352(Suppl 3):SIII1-4.
4. Durukan A, Tatlisumak T. Acute ischemic stroke: Overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav. 2007;87:179-97.
5. Macrae I. New models of focal cerebral ischaemia. Br J Clin Pharmacol. 1992;34:302-8.
6. Takizawa S, Hogan M, Hakim AM. The effects of a competitive NMDA receptor antagonist (CGS-19755) on cerebral blood flow and pH in focal ischemia. J Cereb Blood Flow Metab. 1991;11:786-93.
7. Brinker G, Franke C, Hoehn M, Uhlenkuken U, Hossmann KA. Thrombolysis of cerebral clot embolism in rat: effect of treatment delay. Neuroreport. 1999;10:3269-72.
8. Carmichael Thomas S. Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx. 2005;2:396-409.
9. Gladstone DJ, Black SE, Hakim AM. Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke. 2003;33:2123-36.
10. Cheng YD, Al-Khoury L, Zivin JA. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx. 2004;1:36-45.
11. Corbett D, Nurse S. The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog Neurobiol. 1998;54:531-48.
12. Traversa R, Cicinelli P, Bassi A, Rossini PM, Bernardi G. Mapping of motor cortical reorganization after stroke. A brain stimulation study with focal magnetic pulses. Stroke. 1997;28:110-7.
13. Karbe H, Thiel A, Weber-Luxenburger G, Herholz K, Kessler J, Heiss WD. Brain plasticity in poststroke aphasia: what is the contribution of the right hemisphere? Brain Lang. 1998;64:215-30.
14. Nelles G, Spiekramann G, Jueptner M, Leonhardt G, Muller S, Gerhard H, et al. Evolution of functional reorganization in hemiplegic stroke: a serial positron emission tomographic activation study. Ann Neurol. 1999;46:901-19.
15. Marshall RS, Perera GM, Lazar RM, Krakauer JW, Constantine RC, DeLaPaz RL. Evolution of cortical activation during recovery from corticospinal tract infarction. Stroke. 2000;31:656-61.
16. Calautti C, Leroy F, Guincestre JY, Marie RM, Baron JC. Sequential activation brain mapping after subcortical stroke: changes in hemispheric balance and recovery. Neuroreport. 2001;12:3883-6.
17. Spratt NJ, Fernandez J, Chen M, Rewell S, Cox S, van Raay L, et al. Modification of the method of thread manufacture improves stroke induction rate and reduces mortality after thread-occlusion of the middle cerebral artery in young or aged rats. J Neurosci Methods. 2006;155:285-90.
18. Fox G, Gallacher D, Shevde S, Loftus J, Swayne G. Anatomic variation of the middle cerebral artery in the Sprague-Dawley rat. Stroke. 1993;24:2087-92.
19. Oliff HS, Weber E, Eilon G, Marek P. The role of strain/vendor differences on the outcome of focal ischemia induced by intraluminal middle cerebral artery occlusion in the rat. Brain Res. 1998;675:20-6.
20. Howells D, Porritt M, Rewell S, O'Collins V, Sena E, van der Worp HB, et al. Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab. 2010;30:1412-31.
21. Morand EF, Leech M. Hypothalamic-pituitary-adrenal axis regulation of inflammation in rheumatoid arthritis. Immunol Cell Biol. 2001;79:395-9.
22. Duverger D, MacKenzie ET. The quantification of cerebral infarction following focal ischemia in the rat: influence of strain, arterial pressure, blood glucose concentration, and age. J Cereb Blood Flow Metab. 1988;8:449-61.
23. Oliff HS, Marek P, Miyazaki B, Weber E. The neuroprotective efficacy of MK-801 in focal cerebral ischemia varies with rat strain and vendor. Brain Res. 1996;731:208-12.
24. Oliff HS, Coyle P, Weber E. Rat strain and vendor differences in collateral anastomoses. J Cereb Blood Flow Metab. 1997;17:571-6.
25. Kim SK, Cho KO, Kim SY. The plasticity of posterior communicating artery influences on the outcome of white matter injury induced by chronic cerebral hypoperfusion in rats. Neurol Res. 2008;31:245-50.
26. McColl BW, Carswell HV, McCulloch J, Horsburgh K. Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice. Brain Res. 2004;997:15-23.
27. Bardutzky J, Shen Q, Henninger N, Bouley J, Duong TQ, Fisher M. Differences in ischemic lesion evolution in different rat strains using diffusion and perfusion imaging. Stroke. 2005;36:2000-5.
28. Seok J, Warren H, Cuenca A, Mindrinos M, Baker H, Xu W, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. PNAS. 2013;110:3507-12.
29. Lambertsen KL, Gregersen R, Finsen B. Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent. J Cereb Blood Flow Metab. 2002;22:785-97.
30. Fernandes C, Paya-Cano JL, Sluyter F, D'Souza U, Plomin R, Schalkwyk LC. Hippocampal gene expression profiling across eight mouse inbred strains: towards understanding the molecular basis for behaviour. Eur J Neurosci. 2004;19:2576-82.
31. Li F, Fisher M. Animal modeling for developing stroke therapy. Stroke therapy. Woburn, MA: Butterworth-Heinemann; 2001. pp. 83-96.
32. STAIR. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke. 1999;30:2752-8.
33. Cook DJ, Tymianski M. Nonhuman primate models of stroke for translational neuroprotection research. Neurotherapeutics. 2012;9:371-9.
34. Tagaya M, Liu KF, Copeland B, Seiffert D, Engler R, Garcia JH, et al. DNA scission after focal brain ischemia. Temporal differences in two species. Stroke. 1997;28:1245-54.
35. Huang J, Mocco J, Choudhri T, Poisik A, Popilskis J, Emerson R, et al. A modified transorbital baboon model of reperfused stroke. Stroke. 2000;31:3054-63.
36. Yonas H, Wolfson SK Jr, Dujovny M, Boehnke M, Cook E. Selective lenticulostriate occlusion in the primate: a highly focal cerebral ischemia model. Stroke. 1981;12:567-72.
37. Monsein LH, Mathews VP, Barker PB, Pardo CA, Blackband SJ, Whitlow WD, et al. Irreversible regional cerebral ischemia: serial MR imaging and proton MR spectroscopy in a nonhuman primate model. AJNR Am J Neuroradiol. 1993;14:963-70.
38. Young AR, Touzani O, Derlon J-M, Sette G, MacKenzie ET, Baron JC. Early reperfusion in the anesthetized baboon reduces brain damage following middle cerebral artery occlusion. Stroke. 1997;28:632-8.
39. Liu X, Branston NM, Symon L. Early components of transcallosal responses in acute ischaemia of the corpus callosum. Electroencephalogr Clin Neurophysiol. 1993;88:220-4.
40. Liu X, Branston NM, Kawauchi M, Jellinek DA, Symon L. Electrical stimulation of motor cortex in experimental cortical ischaemia: pyramidal responses at C5 and the surface EMG. Electroencephalogr Clin Neurophysiol. 1992;85:209-14.
41. Vajda J, Branston NM, Ladds A, Symon L. A model of selective experimental ischaemia in the primate thalamus. Stroke. 1985;16:493-501.
42. Ladds A, Branston NM, Vajda J, McGillicuddy JE, Symon L. Changes in somatosensory evoked potentials following an experimental focal ischaemic lesion in thalamus. Electroencephalogr Clin Neurophysiol. 1988;71:233-40.
43. Bentivoglio P, Branston NM, Mayberg M, Habib AH, Symon L. The effects of acute proximal basilar artery occlusion on the primate cerebral circulation. Acta Neurochir (Wien). 1988;95:61-71.
44. Baik MW, Branston NM, Bentivoglio P, Symon L. The effects of experimental brain-stem ischaemia on brain-stem auditory evoked potentials in primates. Electroencephalogr Clin Neurophysiol. 1990;75:433-43.
45. Liu XG, Branston NM, Kawauchi M, Symon L. A model of acute focal ischemia in the territory of the anterior cerebral artery in baboons. Stroke. 1992;23:40-4.
46. Frazee J, Luo X, Luan G, Hinton DS, Hovda DA, Shiroishi MS, et al. Retrograde transvenous neuroperfusion: a back door treatment for stroke. Stroke. 1998;29:1912-6.
47. Nuwer MR. Evoked potential monitoring in the operating room. New York, NY: Raven Press; 1986.
48. Nehls DG, Todd MM, Spetzler RF, Drummond JC, Thompson RA, Johnson PC. A comparison of the cerebral protective effects of isoflurane and barbiturates during temporary focal ischemia in primates. Anesthesiology. 1987;66:453-64.
49. Wey H, Kroma G, Li J, Leland MM, Jones L, Duong TQ. MRI of diffusion-perfusion mismatch in non-human primate (baboon) stroke: a preliminary report. Open Neuroimag J. 2011;5:147-52.
50. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM, et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 2007;357:562-71.
51. Fukuda S, del Zoppo GJ. Models of focal cerebral ischemia in the nonhuman primate. ILAR J. 2003;44:96-104.